We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Endologix Inc | NASDAQ:ELGX | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.22 | 0.2344 | 0.24 | 0 | 01:00:00 |
From May 2019 to May 2024
Event: 23rd Annual Piper Jaffray Health Care Conference
Date: Wednesday, November 30, 2011
Time: 9:30 a.m. ET / 6:30 a.m. PT
Endologix Participant: John McDermott, President and Chief Executive Officer
The second presentation will be at the 6th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference in San Francisco.
Event: 6th Annual Canaccord Genuity Cardiovascular, Diabetes & Obesity Conference
Date: Tuesday, December 6, 2011
Time: 5:00 p.m. ET / 2:00 p.m. PT
Endologix Participant: Bob Krist, Chief Financial Officer
The Third presentation will be at the Oppenheimer 22nd Annual Healthcare Conference in New York City.
Event: Oppenheimer 22nd Annual Healthcare Conference
Date: Tuesday, December 13, 2011
Time: 9:40 a.m. ET / 6:40 a.m. PT
Endologix Participant: John McDermott, President and Chief Executive Officer
An audio webcast of the Company's presentations will be available by visiting the investor relations section of Endologix's website at www.endologix.com. A replay of the presentations will be available for 30 days.
About Endologix, Inc.
Endologix, Inc. (the "Company") develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S. Additional information can be found on Endologix's Web site at www.endologix.com.
Hot Features
Premium
CONTACT: COMPANY CONTACT:
Endologix, Inc.
John McDermott, CEO
(949) 595-7200
www.endologix.com
INVESTOR CONTACTS:
The Ruth Group
Nick Laudico (646) 536-7030
Zack Kubow (646) 536-7020
1 Year Endologix Chart |
1 Month Endologix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
